{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"primary-immunodeficiency-with-post-measles-mumps-rubella-vaccine-viral-infection","columns":[{"gene":"","key":"population-d2f32f2240e7de9b3461","label":"Immunodeficiency 44","mondoId":"MONDO:0014715","onsetQualifier":null,"originColumnKey":"MONDO:0014715/OMIM:616636","originalViews":[{"key":"MONDO:0014715/OMIM:616636","label":"Immunodeficiency 44","scopeLabel":"OMIM:616636","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["0207761cbff3838524a0154d2613fa8796866990446af2a19deea27112732960","101e76002a5999532e9f903274f5e7fcd9c32bd053801ad1b48bb3e88707de87","45fea6be7ce7d89c99b7960afd5b20f483504f20ec37654a639f2b2ca8a34253","8bcb968d7fb8cc1b59fa181a94ecacffc48a1b34e0a65eeed69d8c5d0229079b","9e539d1b463cba905523bde6245b7e1de236aea220a55054458824d8e253d34a","9f0d908b68eb17af6932c06db88a85a4f0a4f350ffb4cf386bffa5da42f3079a","a335dad57cb6b8226f08a43ec9b0e256494f4c91ea767940c5d9e662d39091af","bdf4b1ab8ede5cd937e1092cb04adc54e4452d4f7dee4ca30813b1ad02dcc513","bff98bd2ba3ef65e5b905dcc4f96566925fffefbc83130c37a8f8e8e5fccd2ec","c0e342dedeefacdda8793903ccd1da4166b7af79b060b5aae7b3e40d6d2b74d8"],"recordQualifiers":{},"scopeLabel":"OMIM:616636","sourceIds":["OMIM:616636"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-d2f32f2240e7de9b3461"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0410242","HP:0002720","HP:0002850","HP:0001888","HP:0031964","HP:0040204","HP:0001298"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":9,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":10,"sourceGroups":{"omim":1,"published":9}},"features":[{"hpoId":"HP:0410242","label":"Abnormal circulating IgG concentration","primary":true},{"hpoId":"HP:0002720","label":"Decreased circulating IgA concentration","primary":true},{"hpoId":"HP:0002850","label":"Decreased circulating IgM concentration","primary":true},{"hpoId":"HP:0001888","label":"Decreased total lymphocyte count","primary":true},{"hpoId":"HP:0031964","label":"Elevated circulating alanine aminotransferase concentration","primary":true},{"hpoId":"HP:0040204","label":"Elevated CSF neopterin level","primary":true},{"hpoId":"HP:0001298","label":"Encephalopathy","primary":true},{"hpoId":"HP:0002151","label":"Increased circulating lactate concentration","primary":false},{"hpoId":"HP:0020088","label":"Post-vaccination measles","primary":false},{"hpoId":"HP:0031691","label":"Severe viral infection","primary":false}],"ledeHtml":"Primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection is a rare primary immunodeficiency due to a defect in innate immunity disorder characterized by selective susceptibility to viral infections, particularly after systemic challenge with live viral vaccines, such as the measles, mumps and rubella (MMR) vaccine. Patients present severe, potentially fatal, manifestations to viral illness, including encephalitis, hepatitis and pneumonitis.","mondoId":"MONDO:0014715","node":{"canonicalSlug":"primary-immunodeficiency-with-post-measles-mumps-rubella-vaccine-viral-infection","comparisons":[{"documentSha256":"3f35464847da4c116e3781368c21ee0f82e1dd22dfbbea5dfabfa85bebe82178","key":"legacy-primary-immunodeficiency-with-post-measles-mumps-rubella-vaccine-viral-infection","kind":"legacy","label":"primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection","memberIds":["MONDO:0014715"],"mondoId":"MONDO:0014715","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/primary-immunodeficiency-with-post-measles-mumps-rubella-vaccine-viral-infection.3f35464847da4c116e3781368c21ee0f82e1dd22dfbbea5dfabfa85bebe82178.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection","originalSourceId":"ORPHA:431166","paragraphs":["Primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection is a rare primary immunodeficiency due to a defect in innate immunity disorder characterized by selective susceptibility to viral infections, particularly after systemic challenge with live viral vaccines, such as the measles, mumps and rubella (MMR) vaccine. Patients present severe, potentially fatal, manifestations to viral illness, including encephalitis, hepatitis and pneumonitis."],"rawAttribution":"MONDO:0014715","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-21T17:02:47Z","upstream":"MONDO:0014715","url":"https://rarediseases.info.nih.gov/diseases/17711"},"ownColumnKeys":["population-d2f32f2240e7de9b3461"],"publication":"published","relationships":[{"kind":"parent","label":"inborn error of immunity","mondoId":"MONDO:0003778","slug":"inborn-error-of-immunity"},{"kind":"parent","label":"immunodeficiency disease","mondoId":"MONDO:0021094","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"count","key":"0207761cbff3838524a0154d2613fa8796866990446af2a19deea27112732960","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:616636","disease_name":"Immunodeficiency 44","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0031964","is_excluded":false,"label":"Elevated circulating alanine aminotransferase concentration","onset_id":null,"reference":"PMID:26122121","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"101e76002a5999532e9f903274f5e7fcd9c32bd053801ad1b48bb3e88707de87","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:616636","disease_name":"Immunodeficiency 44","evidence":"PCS","frequency_raw":"1/5","hpo_id":"HP:0020088","is_excluded":false,"label":"Post-vaccination measles","onset_id":null,"reference":"PMID:23391734","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"45fea6be7ce7d89c99b7960afd5b20f483504f20ec37654a639f2b2ca8a34253","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:616636","disease_name":"Immunodeficiency 44","evidence":"PCS","frequency_raw":"3/5","hpo_id":"HP:0031691","is_excluded":false,"label":"Severe viral infection","onset_id":null,"reference":"PMID:23391734","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"8bcb968d7fb8cc1b59fa181a94ecacffc48a1b34e0a65eeed69d8c5d0229079b","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:616636","disease_name":"Immunodeficiency 44","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0040204","is_excluded":false,"label":"Elevated CSF neopterin level","onset_id":null,"reference":"PMID:26122121","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"9e539d1b463cba905523bde6245b7e1de236aea220a55054458824d8e253d34a","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:616636","disease_name":"Immunodeficiency 44","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0002151","is_excluded":false,"label":"Increased circulating lactate concentration","onset_id":null,"reference":"PMID:26122121","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"9f0d908b68eb17af6932c06db88a85a4f0a4f350ffb4cf386bffa5da42f3079a","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:616636","disease_name":"Immunodeficiency 44","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0002850","is_excluded":false,"label":"Decreased circulating IgM concentration","onset_id":null,"reference":"PMID:26122121","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"a335dad57cb6b8226f08a43ec9b0e256494f4c91ea767940c5d9e662d39091af","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:616636","disease_name":"Immunodeficiency 44","evidence":"PCS","frequency_raw":"0/2","hpo_id":"HP:0410242","is_excluded":true,"label":"Abnormal circulating IgG concentration","onset_id":null,"reference":"PMID:26122121","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"bdf4b1ab8ede5cd937e1092cb04adc54e4452d4f7dee4ca30813b1ad02dcc513","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:616636","disease_name":"Immunodeficiency 44","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001298","is_excluded":false,"label":"Encephalopathy","onset_id":null,"reference":"OMIM:616636","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"bff98bd2ba3ef65e5b905dcc4f96566925fffefbc83130c37a8f8e8e5fccd2ec","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:616636","disease_name":"Immunodeficiency 44","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0002720","is_excluded":false,"label":"Decreased circulating IgA concentration","onset_id":null,"reference":"PMID:26122121","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"c0e342dedeefacdda8793903ccd1da4166b7af79b060b5aae7b3e40d6d2b74d8","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:616636","disease_name":"Immunodeficiency 44","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0001888","is_excluded":false,"label":"Decreased total lymphocyte count","onset_id":null,"reference":"PMID:26122121","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/17711\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0014715\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>MONDO:0014715</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection is a rare primary immunodeficiency due to a defect in innate immunity disorder characterized by selective susceptibility to viral infections, particularly after systemic challenge with live viral vaccines, such as the measles, mumps and rubella (MMR) vaccine. Patients present severe, potentially fatal, manifestations to viral illness, including encephalitis, hepatitis and pneumonitis.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/17711\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"primary-immunodeficiency-with-post-measles-mumps-rubella-vaccine-viral-infection","sourceDocuments":[{"name":"GARD: Primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection","reviewed":null,"source_release":"2026-10-21T17:02:47Z","url":"https://rarediseases.info.nih.gov/diseases/17711"},{"name":"MONDO: primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0014715"}],"sourceNote":"","synonyms":["IMD44","immunodeficiency 44","immunodeficiency type 44","primary immunodeficiency with post-MMR vaccine viral infection"],"takeawayHtml":"","title":"primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection"},"schemaVersion":1}
